Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (otvara se novi prozor)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Izvor‎: Pediatr Transplant 2017;21(6):e13017.

Indeks‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (otvara se novi prozor)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (otvara se novi prozor)

Bhatia M, Davenport V, Cairo MS.

Izvor‎: Leuk Lymphoma 2007;48(1):9-15.

Indeks‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (otvara se novi prozor)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (otvara se novi prozor)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Izvor‎: Lancet 2003;361(9354):275-80.

Indeks‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (otvara se novi prozor)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (otvara se novi prozor)

Fassel H, Bussel JB, Roberts SS, Modak S

Izvor‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

Indeks‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (otvara se novi prozor)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (otvara se novi prozor)

Jacobson AE, Shah N, Setty BA

Izvor‎: Pediatr Blood Cancer 2017;64(8):e26473.

Indeks‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (otvara se novi prozor)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (otvara se novi prozor)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Izvor‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

Indeks‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (otvara se novi prozor)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (otvara se novi prozor)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Izvor‎: Int J Hematol 2015;102(5):626-32.

Indeks‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (otvara se novi prozor)

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. (otvara se novi prozor)

Porter JC, Leahey A, Polise K, Bunin G, Manno CS

Izvor‎: J Pediatr 1996;129(5):656-60.

Indeks‎: PubMed 8917229

DOI‎: 10.1016/s0022-3476(96)70145-2

https://www.ncbi.nlm.nih.gov/pubmed/8917229 (otvara se novi prozor)

Chemotherapy induced thrombocytopenia in pediatric oncology. (otvara se novi prozor)

Tamamyan G, Danielyan S, Lambert MP

Izvor‎: Crit Rev Oncol Hematol 2016;99:299-307.

Indeks‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (otvara se novi prozor)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (otvara se novi prozor)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Izvor‎: Onkologie 2004;27(2):131-7.

Indeks‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (otvara se novi prozor)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (otvara se novi prozor)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Izvor‎: Ann Oncol 2005;16(1):139-45.

Indeks‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (otvara se novi prozor)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (otvara se novi prozor)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Izvor‎: Blood 1998;91(10):3601-6.

Indeks‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (otvara se novi prozor)